Whole-body Magnetic Resonance Imaging as a Treatment Response Biomarker in Castration-resistant Prostate Cancer with Bone Metastases: The iPROMET Clinical Trial,European Urology

当前位置： X-MOL 学术 › Eur. Urol. › 论文详情

Our official English website, www.x-mol.net, welcomes your feedback! (Note: you will need to create a separate account there.)

Whole-body Magnetic Resonance Imaging as a Treatment Response Biomarker in Castration-resistant Prostate Cancer with Bone Metastases: The iPROMET Clinical Trial
European Urology ( IF 23.4 ) Pub Date : 2024-03-14 , DOI: 10.1016/j.eururo.2024.02.016
Alonso Garcia-Ruiz , Carlos Macarro , Francesca Zacchi , Rafael Morales-Barrera , Francesco Grussu , Irene Casanova-Salas , Francesco Sanguedolce , Macarena Gonzalez , Pablo Cresta-Morgado , Matias de Albert , Josep Garcia-Bennett , David Marmolejo , Jacques Planas , Sarai Roche , Richard Mast , Christina Zatse , Josep M Piulats , Bernardo Herrera-Imbroda , Lucas Regis , Laura Agundez , David Olmos , Nahum Calvo , Manuel Escobar , Joan Carles , Joaquin Mateo , Raquel Perez-Lopez

中文翻译：